Actavis and ASKA finalize agreement for generic pharmaceutical company in Japan
Actavis Group and Japan’s ASKA Pharmaceutical have formally signed an agreement establishing a joint company: Actavis ASKA K.K. with its head office i...
Actavis in business alliance with a Japanese generic pharmaceutical manufacturer
Actavis announced a preliminary agreement with ASKA Pharmaceutical concerning the establishment of a joint company: Actavis ASKA Co., Ltd. The plan is...
Actavis steps into the South Korean generics market
The international generic pharmaceuticals company, Actavis has entered into an exclusive distribution agreement with J&M Pharma, a Korean owned an...
Actavis pharmaceuticals unaffected by Iceland crisis
Pharmaceutical giant Actavis has released a statement saying it’s business as normal for the global generic drugs company. Actavis has said that its o...
Actavis receives US approval for antidepressant drug
Actavis, a generic drug manufacturer based in Iceland, has received approval from the US Food & Drug Administration to market the generic drug equ...
New leadership at Actavis pharmaceuticals
Actavis has announced a number of senior appointments at the international generic drugs company. Gudbjorg Edda Eggertsdottir has been appointed as De...
Actavis helps disabled in Bulgaria
Actavis, a generic drugs manufacturer based in Iceland, has completed the latest project in its campaign to make some of Bulgaria’s most important spi...
Robert Wessman to speak at UBS pharmaceuticals conference
The CEO of Actavis generic pharmaceuticals, Robert Wessman, is scheduled to speak at the annual UBS Global Specialty and Generic Pharmaceuticals Confe...